Aarey Drugs & Pharmaceuticals Limited (BOM:524412)

India · Delayed Price · Currency is INR

103.05

+0.58 (0.57%)

At close: Oct 1, 2026

Market Cap	2.93B +25.2%
Revenue (ttm)	4.15B -7.7%
Net Income	36.20M -12.9%
EPS	1.27 -14.0%
Shares Out	28.45M
PE Ratio	81.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,106
Open	105.75
Previous Close	102.47
Day's Range	102.65 - 107.55
52-Week Range	50.40 - 107.55
Beta	1.24
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About BOM:524412

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, ... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1990

Employees 132

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524412

Full Company Profile

Financial Performance

In fiscal year 2026, BOM:524412's revenue was 4.72 billion, a decrease of -0.35% compared to the previous year's 4.74 billion. Earnings were 39.68 million, a decrease of -1.40%.

Financial Statements